Theovog 0.3mg Tablet
Marketer
Theogen Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Theovog 0.3mg Tablet
Diabeva 0.3mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. This medication is prescribed when dietary changes and other antidiabetic therapies prove insufficient to maintain blood glucose within the target range. Diabeva 0.3mg should be ingested immediately before meals; dosage and frequency are determined individually by your physician to optimize glycemic control. Discontinue use only under medical supervision; abrupt cessation may result in dangerously elevated blood sugar, potentially causing serious complications like renal impairment or vision loss. This medication forms part of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include abdominal discomfort, altered appetite, bowel irregularities (constipation or diarrhea), and flatulence. Report any persistent or bothersome side effects to your doctor. While Diabeva 0.3mg alone does not induce hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) elevates this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Prior to commencing treatment, inform your physician of any liver or kidney conditions. This medication is contraindicated in patients with inflammatory bowel disease (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice before initiating treatment. Comprehensive disclosure of all medications currently being taken is crucial for safe use. Limit alcohol consumption as excessive intake may increase the risk of hypoglycemia.
Uses of Theovog 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Theovog 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Theovog 0.3mg Tablet whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
Common Side effects of Theovog 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Theovog 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Theovog 0.3mg tablets should be taken on an empty stomach.
How Theovog 0.3mg Tablet works:
The oral medication Theovog 0.3mg, classified as an anti-diabetic agent, functions by suppressing the activity of intestinal enzymes that digest complex carbohydrates into simpler sugars like glucose. Consequently, postprandial blood sugar spikes are significantly reduced.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Theovog 0.3mg Tablets should not be taken together.
PregnancySAFE IF PRESCRIBED
Pregnant women can generally use Theovog 0.3mg tablets safely. Animal studies indicate minimal or no harm to the unborn; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Theovog 0.3mg tablets without significant risk to their infants. Available human data indicates minimal potential harm to the baby.
DrivingSAFE
Driving ability is typically unaffected by Theovog 0.3mg Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Theovog 0.3mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Theovog 0.3mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Theovog 0.3mg Tablet :
Omit any missed Theovog 0.3mg Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Theovog 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently